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Neurofibromatosis type 1 (NF1) is a neurocutaneous disorder associated with lifelong tumor
growth propensity and neurocognitive impairments. Although follow-up of adults with NF1 often
focuses on tumor growth, follow-up of cognitive or social problems and other NF1-related comor-
bidity is often not a part of standardized care. In order to provide optimal care services for these
patients, we explored the care needs of adults with NF1. A qualitative study was performed using
semi-structured group interviews, exploring worries and care needs in medical, psychological, and
socioeconomic domains, also focusing on the transition from pediatric to adult care. Four focus
groups were conducted, including young adult patients, patients over age 30, and parents of young
adult patients. In total, 30 patients and 12 parents participated. Data were transcribed verbatim
and analyzed by computerized thematic analysis. Themes were organized using the World Health
Organization International classification of functioning, disability, and health (ICF). Results indicated
many and diverse worries and care needs both during the transitional period and in adulthood in
medical, mental health, and socioeconomic domains. Worries could be categorized into 13 themes.
Parents reported high stress levels and difficulties with their parental role. Participants expressed
the need for more information, access to NF1 experts, daily living support, care for mental health
and socioeconomic participation, and closer communication between health-care providers. In con-
clusion, worries and needs of patients and parents underline the importance of multidisciplinary
follow-up and continuity of care during and after the transitional period. Additionally, parental
stress requires more attention from care providers.
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1 | INTRODUCTION
Neurofibromatosis type 1 (NF1) is a relatively common autosomal
dominant neurocutaneous disorder with an estimated birth incidence of
1/2,700 (Evans et al., 2010). Approximately 40% to 50% of the cases
are caused by a de novo mutation in the NF1 gene (Evans et al., 2010;
Friedman, 1999). Clinical features of NF1 include multiple cafe-au-lait
spots, axillary and inguinal freckling, multiple cutaneous neurofibromas,
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; ASD, autism
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International classification of functioning, disability, and health; ISCED,
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and iris Lisch nodules (NIH, 1987). Serious complications of NF1 include
different types of tumor formation, such as central nervous system glio-
mas and plexiform neurofibromas, with a risk of evolving into malignant
peripheral nerve sheath tumors (MPNSTs) (Ferner & Gutmann, 2013)
for which guidelines for neuro-oncological follow-up are available. How-
ever, although neuropsychiatric and psychosocial problems persist into
adulthood, currently these are often not routinely addressed in adults.
Learning disabilities occur in at least 50% of children with NF1,
making cognitive problems the most common complication to affect
the quality of life in this group (Hyman et al., 2005). Attention-deficit/
hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and
sleep disturbance are also highly prevalent (Hyman et al., 2006;
Leschziner et al., 2013; Morris et al., 2016) and can persist throughout
life (Constantino et al., 2015; Descheemaeker et al., 2013; Mautner
et al., 2015; van Eeghen AM et al., 2013). Furthermore, patients with
NF1 are at risk for psychosocial problems. In adolescence and adult-
hood, the dermatological and neuronal tumor phenotype can exacer-
bate in a period in which appearance, acceptance, and social inclusion
are of great importance (Van Lierde et al., 2013; Vranceanu et al.,
2015). Additionally, the impaired socialization, low self-esteem, and
poor interpretation of social cues reported in children with NF1 (Lehto-
nen et al., 2013) may limit social participation in adulthood. Even when
adults with NF1 receive care for the tumor growth phenotype, appro-
priate care for other NF1-related morbidity is often not part of standar-
dized care (Farre et al., 2016).
For patients with NF1, international health-care guidelines advise
multidisciplinary follow-up including evaluation of tumor growth,
dermatological manifestations, and neuropsychiatric disorders (Korf,
2015; Rauen et al., 2015). Although pediatric patients often receive
and adhere to this multidisciplinary care, studies show that young
adults with NF1 may have poor access to health care, limited disease
knowledge, and are often lost to follow-up. At the same time, they
have a high complication rate and neuropsychiatric and socioeconomic
problems persisted or worsened (Oates et al., 2013). Adult patients
with NF1 experience decreased quality of life (Vranceanu et al., 2013)
and they require developmentally appropriate care (Farre et al., 2016).
Thus far, limited data are available on the full scope of worries and
health-care needs of young adults and adults with NF1 and their parents.
Previous qualitative studies have focused on the impact of NF1 in adult-
hood, for instance, addressing the effects of plexiform neurofibromas (Lai
et al., 2017), health and well-being, quality of life, and transition to adult
care (Barke et al., 2014; Crawford et al., 2015; Draucker et al., 2017; Van
Lierde et al., 2013). The aim of the current study was to provide more
information on the full spectrum of worries and care needs in medical,
psychological, social, and economic domains of adults with NF1 and
parents of patients with NF1. Using patient-driven data, we formulate
recommendations for health-care providers (HCPs) in order to optimize
health care for this vulnerable patient group.
2 | MATERIALS AND METHODS
A qualitative design with semi-structured group interviews was used to
obtain in-depth data on worries and care needs of patients and their
parents. The full spectrum of care needs was explored, including medi-
cal, psychological, social and societal domains, and contextual factors.
The COREQ (consolidated criteria for reporting qualitative studies)
checklist was used as a reporting framework for this qualitative study
(Tong et al., 2007).
2.1 | Participants
Convenience sampling was performed in close cooperation with the neu-
rofibromatosis patient organization of The Netherlands (NFVN). Young
adults (18–30 years) and older adults (30–67 years) with NF1 and parents
of patients with NF1 were invited to join focus groups, which were con-
ducted on April 16, 2016, at a conference center in the Netherlands after
the annual meeting of the NFVN. This annual meeting is generally visited
by 50 to 100 patients, parents of patients, and professionals. The invitation
was part of the agenda that was sent to all members of this association.
Inclusion criteria for the patients were that they must be 18 years of age
or older, and have a diagnosis of NF1 (as stated by the participating mem-
bers, not necessarily confirmed by DNA testing). The inclusion criterion for
parents was having a child with NF1 who is now an adult. Participation of
parents was not dependent on their child’s participation or vice-versa.
Participants were divided into four focus groups: 1) patients aged 18
to 30 years, 2) parents of patients aged 18 to 30 years, 3 and 4) two
groups of patients and parents of patients aged over 30. The cut-off point
of 30 years was based on the European Commission definition of “youth
and young people” (European-Commission, 2007), evidence that neurode-
velopment continues up to the age of 30 years old, and clinical experience
that the transitional period can be protracted in patients with neurodeve-
lopmental disorders. Both groups 3 and 4 were mixed groups of parents
and patients, who indicated they wanted to join the groups together. In
total, 12 parents participated, including four fathers and eight mothers.
2.2 | Data collection
Focus groups were 90 min in length and were moderated by a pediatri-
cian (RO), an intellectual disability physician (AE), and two psychologists
(AR, JL). Moderators were specifically allocated to ensure they had no
treatment relationships with participants. Prior to the focus group,
moderators received training to ensure consistency across interviews.
Two observers (HH and PB) joined the focus groups.
Semi-structured interviews contained previously drafted questions
and probes on worries and needs in medical, psychological, and socioe-
conomic domains (see Table 1). Participants were explicitly asked to
discuss the transitional phase between pediatric and adult care. In the
Netherlands, the transition from pediatric to adult health care usually
occurs at approximately 18 years of age (van Staa et al., 2011).
2.3 | Data analysis
Focus groups were digitally recorded and transcribed verbatim.
Transcripts were imported into the qualitative software package
ATLAS.ti 6.2 (ATLAS.ti, 2011). Thematic analysis (Braun & Clarke,
2006) was selected for its theoretical freedom and yield of rich and
detailed account of data.
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All transcripts were reviewed and coded by a member of the
research team (HH). Initial codes were based on the overall subject of a
text fragment. During analysis, initial codes were modified, expanded,
or merged as new issues emerged. Decisions about the codes were
made based on the most complete representation of the data. Sub-
themes were merged where possible. To enhance validity, the coding
process and the emerging themes were continually discussed with two
co-investigators (PB, AE), and in an additional meeting with other co-
investigators themes were discussed until consensus was reached.
After obtaining a consensus on the open coding, worries and care
needs were organized based on the International classification of func-
tioning, disability, and health (ICF) framework. The ICF is a classification
of health and related domains, published in 2001 by the World Health
Organization (WHO 2001), and describes impairments of body func-
tions and structures, activity limitations, participation restriction, and
environmental factors. It is used as a framework to express health and
disability using individual and population measures and has been used
for holistic evaluation and interpretation of NF1-related disabilities in
pediatric patients (Gilboa et al., 2010). A valuable contribution of the
ICF classification is the emphasis on the effects of health issues on
activities and social and economic (socioeconomic) participation.
Socioeconomic participation is defined as a person’s involvement in a
life situation and the socioeconomic domain represents the societal
perspective of functioning. The theme “parental stress” was classified
as an environmental factor for the patient, since parents are part of the
environment they live in. “Problems during transition phase” were also
considered an environmental factor since the current health-care
infrastructure appeared to contribute to these problems.
The education of patients was classified according to the interna-
tional classification of education (ISCED 2011) (UNESCO Institute for
Statistics, 2012).
2.4 | Ethical approval
This study was approved by the Medical and Ethical Review
Committee (MEC) of the Erasmus Medical Centre (ref. MEC-2016-
532). For all participants and recordings, informed consent was
obtained and a formal review and waiver of the MEC was given.
3 | RESULTS
3.1 | Participants
Forty-two participants were included; 30 patients and 12 parents (see
Table 2 for patient characteristics). The age of patients ranged from 18
TABLE 1 Abbreviated interview guide
Key questions:
1) What are your worries about. . .
2) What are your care needs for. . . Probes
Transition from pediatric to adult care? Transition to adult health care, change in physician, transition to adult life, transition to work,
independent living
Medical issues? Symptoms, NF1-related care, medication, care consultations
Psychological and behavioral issues? Sleeping problems, ADHD, ASD, depression, anxiety
Social life? Friendships, romantic relationships, family, family planning, loneliness, sexuality
Work and daily activities? Work, school, independence, finances, daily living
Paramedical issues? Language problems, nutrition, motor skills
TABLE 2 Description of the study sample
Focus groups
Characteristics (1) Patients 18–30
(2) Parents of
patients 18–30
(3 and 4) Parents and
patients 301 Total
Patients (N) 12 – 18 30
Parents (N) – 7 5 12
Age of patients in years
(Median, interquartile range)
24.5 (22.3–29.5) 53.5 (36–59.5) 36.0 (27.3–55.5)
Gender of patients:
Female N (%)
Male N (%)
8 (67)
4 (33)
6 (33)
12 (67)
14 (47)
16 (53)
Highest level of education of the patient, N (%):
Primary-lower secondary (ISCED 1–2)a
Upper-postsecondary (ISCED 3–4)
Bachelor-university degree (ISCED 5–7)
1
8
3
3b
7
7
4b
15
10
aISCED: International classification of education.
bInformation on education of one patient missing.
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to 67 years, while the age of parents ranged from 54 to 75 years. The
NF1-mutation status of parents was unknown. After transcription and
coding, 13 major themes were identified and classified using the ICF
(Table 3 provides an overview). The ICF-framework proved to be a
useful tool in organizing the diversity of worries and needs ensuring an
overview of both functional impairments and their consequences in
daily life. Detailed results of the analysis of the transcript are provided
below. The addition of new codes diminished greatly during analysis,
suggesting data saturation.
4 | IMPAIRMENT OF BODY FUNCTIONS
AND STRUCTURES
4.1 | Mental health problems
High levels of anxiety and stress were broadly discussed, such as fear of
failure, social anxiety, and fears and worries about the future. Symptoms
of depression were also discussed in all focus groups, as several patients
reported needing antidepressants and psychological consultations. Both
patients and parents noted problems with emotion and mood regulation,
leading to anticipatory stress and frustration by family members.
Anxiety is always present, you know. Fear of new
situations, and also fear of meeting new people. I see it
in my son, even when he needs to go into a new store.
So every time he goes somewhere new for the first
time, he wants me to join him.—Parent 18–30
Difficulties with self-acceptance and coping with the disease were
widely present. Especially patients in the 301 focus groups mentioned
that it would have been helpful if psychological care had been offered.
Various patients noted that the disorder of NF1 itself limited their cop-
ing skills: fatigue, anticipatory stress, and a depressed mood made them
feel less resilient.
4.2 | Worries about the future
The unpredictable course of NF1 was a major concern of patients.
Patients worried about future symptoms and prognosis, future loss of
functions, future surgery, future esthetic problems, malignant transfor-
mation of neurofibromas in the future, obtaining relationships, and
achieving independence.
It is just that you don’t know how it will be. Really
everything is worrisome.—Patient 18–30
4.3 | Cognitive deficits
Language and speech problems were mentioned and some adults
received speech therapy. Not many cognitive deficits or learning
TABLE 3 ICF categories, themes, and corresponding codes
ICF classification Themes Codes
Impairment of body
functions and
structures
Mental health problems Anxiety, worries in many areas, symptoms of depression, problems with emotion and
mood regulation, ADHD symptoms, ASD symptoms, problems coping with having
NF1,a problems with self-acceptancea
Worries about the future Worries about future symptoms and prognosis
Cognitive deficits Learning disabilities, language, and speech problems
Physical problems Sleeping problemsa, fatigue, headache, pain, growth of neurofibromas, unexplained
physical complaints
Visibility of disability Problems with visibility of NF1, focus of others on external featuresa
Activity limitations &
participation
restriction
Limitation of independence Difficulties adjusting life to complications of NF1a, difficulty reaching independence,
patient does not recognize and/or seek help for NF1 symptomsb, problems with
planninga and organizing
Social deficits limit
participation
Lack of self-confidence,a trouble with initiating and maintaining social and romantic
relationships, loneliness
Family planning difficulties Worries about the risk of passing NF1 to offspring,a worries about medical
procedures to have children, uncertainty about obtaining a relationship
Limitations with work Unable to work full time, overestimation, difficulties with finding and keeping workb
Environmental
factors
Required support in daily life Support of parents, support of network, support of patient association, involvement
of health care professionals in living and working
arrangements
Problems during transition
process
Protracted transition,b buddy needed in transition time, no consultation between
doctors, unsuccessful transition
Limited access to adequate
care in various domains
Knowledge of NF1 absent in doctors, lack of mental health care,a difficult to find an
NF1 expert.b Need for one contact person instead of multiple health-care
providers,a need for communication between health-care providers, need for
multidisciplinary care,a need for family planning care,a support for parents,b need
for more social and societal assistance
Parental stress No acknowledgment of worries of the parent by care providers,b much time spent on
assistance and administration,b confusion about parental role,b decreased quality
of parent–child relationshipb
aMainly discussed by patients.
bMainly discussed by parents.
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problems were presented as worries, although their dependence on
others was often mentioned. Some parents had the impression that
cognitive development stopped or slowed during the transition period
because their children reached independence much later than their
peers.
. . . That’s where I have question marks. I wonder if
development in those children, in young adults under
age 30, if there is still progress.—Parent 18–30
4.4 | Physical problems
There was great diversity in the experienced physical problems. Sleeping
problems, fatigue, headache, and limited motor skills often expressed as
“clumsiness” had a major impact on daily life. Fatigue and headaches
had a large effect on the ability to work full time and to participate in as
many activities as peers. Various sleeping problems were reported as a
concern; difficulty falling asleep, difficulty staying asleep, difficulty
waking up, and need for sleep medication. Furthermore, the growth of
neurofibromas was mentioned as a major cause of frustration, because
of possible malignant transformation and changing appearance.
Symptoms mentioned by a small group of patients were pain, back pain,
and scoliosis. Limited motor skills had a more indirect impact on the lives
of the patients, for instance being unable to cycle or swim.
4.5 | Visibility of disability
Patients noted being watched, stared at, and/or insulted in public pla-
ces because of their cosmetic problems. The visibility of the disease
caused questions from outsiders which were perceived as annoying,
for example, questions about contagiousness.
It was hinted that I had to leave the pool because others
had problems with me being in the pool.—Patient 301
Particularly the younger patients were annoyed about NF1-portrayal
in media, for example, only the worst cases being shown on television
or the internet, resulting in a false perception of NF1.
There was a documentary also about (person’s name),
and it’s always about getting the worst, very worst, the
worst of all . . . and showing the most severe [cases]. . .
—Patient 18–30
5 | ACTIVITY LIMITATIONS AND
PARTICIPATION RESTRICTION
5.1 | Limitation of independence
Parents and patients mentioned their worries about achieving inde-
pendence. Parents reported that their children with NF1 lacked
initiative. Young adults emphasized that achieving independence was
delayed; some patients wanted to complete school before moving out
of their parent’s house. Those who lived independently stated that
they needed assistance in housekeeping, planning, and organizing.
Patients had trouble asking for help, resulting in having to wait for
people offering assistance. Additionally, patients encountered problems
adjusting their lives to their limitations caused by NF1, for example,
planning too many activities while at the same time having limited
energy.
I’m having a hard time becoming independent, and it’s
very scary to separate from my parents and to do it all
by myself.—Patient 18–30
Many parents remained in the coordinating role regarding medical
affairs and participated in visits with medical specialists, claiming that
patients did not recognize and seek help for NF1 symptoms.
5.2 | Social deficits
Loneliness and trouble initiating and maintaining social and romantic
relationships were the main social problems. Some of the young
adults stated to have had social skills training in the past. Further-
more, patients feared a lack of understanding of NF1 in new social
contacts. Both patients and parents mentioned that friendships
were complicated by limited understanding of the disorder in their
environment.
Yes, obtaining friendships is difficult because she [my
daughter] sometimes behaves a bit awkward.—Parent
18–30
Especially among patients between 18 and 30, feelings of insecurity
and low self-esteem were reported. They felt that they were
“different” from others and wanted to be “normal.” Many patients
were still trying to cope with bullying in their past and some patients
even mentioned this prior bullying “still influenced their current
social skills.”
5.3 | Family planning difficulties
There were many worries regarding family planning. Patients appeared
to be informed that they could pass NF1 to their offspring, but
discussed their need for timely and adequate information and care on
this issue. Some of the patients mentioned the desire to have children
but felt uncertain about obtaining a relationship which would allow for
that in the future.
I want children, but do not want to inflict upon them
the life that I’m leading, [. . .] so yes, you have to go into
that trajectory, but who with, and how, and adopting is
an option, but then you can’t give birth, and yes, I’m
twenty now and I do not have a partner, and I’m getting
older. . .—Patient 18–30
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5.4 | Limitations with work
For cognitively high-functioning patients (ISCED levels 5–7), fatigue
was a large cause of problems at work. They felt unable to work full
time, but the reduction of working hours was not always allowed by
their employers. Patients mentioned the need for assistance with
employment matters, for example: obtaining a suitable job, obtaining a
permanent contract, overestimation of abilities, lack of understanding
of disabilities, and unequal treatment at work. A job coach or specific
organizations were often deployed, but not always successfully.
Parents indicated the need for involvement of HCPs in living and work-
ing arrangements.
Fatigue, headaches . . . there is zero understanding . . .—
Parent 18–30
Actually, in my view, a coordinating physician should
refer to rehabilitation doctors earlier, or that for the
home/work situation a medical advice is provided,
about how to proceed with such a child. . .—Parent
18–30
6 | ENVIRONMENTAL FACTORS
6.1 | Required support in daily life
Parents and patients all mentioned the need for support and recogni-
tion, and many of them found this in peer groups of the national patient
association. Also, they appreciated people in their direct networks
showing interest in NF1, both in real life and in social media networks.
. . . in the peer group, we recognize each other there,
fortunately, we are very happy with the patient founda-
tion because we feel supported.—Parent 18–30
6.2 | Problems during transition process
Many of the patients declared that the transition to adult health care
had been hampered by a lack of communication about the transition to
adult care, lack of organization of adequate follow-up, lack of consulta-
tion between physicians, and lack of referral to expert care. Often,
patients were referred back to their general practitioner (GP) for adult
care. Parents noted that contrary to their expectations, care needs
increased after becoming 18.
6.3 | Limited access to adequate care
A number of patients noted that they appreciated when their GP was
closely involved. Patients noted the lack of communication and consul-
tations between physicians. Generally, it was very difficult to find
physicians with knowledge and experience with NF1, and often second
opinions were required. Patients from outside NF1 expertise centers
were not referred to appropriate adult care by their GP’s or pediatri-
cians. Psychological support during intensive treatments (e.g., facial
surgery) was not often offered but mentioned as a care need by various
patients. Parents felt that their child received inadequate care if parents
were not involved.
Some physicians, they didn’t know the disorder and
they had to sometimes “google” during the consultation,
and that I find absolutely unacceptable, personally.—
Patient 18–30
Patients and parents indicated a need for one easily accessible
contact person for NF1-related questions, surrounded by a multidisci-
plinary team. Also, they were in need of family planning care, social
assistance and community support, and support for parents. During the
focus groups, the question was raised about whether the expertise
center could provide information about NF1 to employers, health insur-
ance companies, and social security offices. These organizations have a
lack of knowledge about NF1 and patients would benefit if they would
have more information. Interestingly, parents noted that short-term
thinking was helpful for their child, because of their slower develop-
ment and the unpredictable course of NF1. As remarks about possible
long-term effects of NF1 were not found to be useful and unnecessa-
rily stressful, parents also advised professionals surrounding the NF1-
patient to use “short-term thinking” with short-term recommendations.
6.4 | NF1-related stress in parents
Parents were particularly concerned about their children not recogniz-
ing NF1-related symptoms such as (growth of) neurofibromas, not
seeking health care, not receiving proper transitional care, and losing
their child to the complications of NF1. Parents worried about the slow
development of independence and the vulnerability of their child (e.g.,
risking abuse). Many parents reported high stress and fatigue levels
due to their persistent coordinating role in the lives of their children—
spending much time with the planning, organization, and administration
of daily life and medical issues. Some parents even acted as a legal rep-
resentative. Consequently, by having the coordinating role, the ques-
tion arose: “Who will take care of our child when we are no longer able
to do so in the future?” Parental concerns were generally not acknowl-
edged or addressed by HCPs or people in their environment, leading to
increased stress.
. . . Listen to us, really hear us, even when it seems exag-
gerated.—Parent 18–30
7 | DISCUSSION
This study offers patient- and parent-driven data on worries and care
needs of adult patients with NF1, with an emphasis on the transitional
period. Worries emerged from a broad spectrum of areas, ranging from
physical and mental health to areas of social and occupational participa-
tion, and transition. This enabled us to formulate recommendations for
transitional and adult care.
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7.1 | Physical health
Physical symptoms such as fatigue, headaches, sleeping problems, and
pain had a large effect on daily life and were the cause of many worries
and medical consultations. Most of these generally nonspecific symp-
toms have been reported in children, adolescents, and adults with NF1
(Afridi et al., 2015; Johnson et al., 2005; Leschziner et al., 2013;
Wolters et al., 2015). Although tumor growth must be excluded, further
clinical evaluation often indicates that these physical complaints may
be associated not only with NF1, but also with mental health, lifestyle,
or problems at work. Patients pointed out they wished to know
whether these complaints were associated with NF1. Since these com-
plaints have a great impact on quality of life, referral to psychological
or occupational care is warranted to cope with these symptoms. Differ-
ent levels of care may help to answer these questions regarding the
role of NF1 in any of these problems. A health-care model with an NF1
expertise center, coordinating NF1-specialists, and several regional
treatment centers (a “hub-and-spoke” model, the way complex NF1
services are organized in the United Kingdom) may facilitate close
cooperation of GP’s with a center that offers the appropriate level of
care.
7.2 | Mental health
Although many psychological worries were reported, most participants
noted a lack of routine assessment of these problems and experienced
difficulties finding appropriate evaluation and treatment. Fears and
worries about the future occurred very frequently on many different
topics and potential growth of neurofibromas was especially worrisome
to the participants. Symptoms of depression and anxiety are frequently
found in patients with NF1 (Cohen et al., 2014; Pasini et al., 2012)
which may be related to the risk of development of malignancies, as is
the case in patients at risk for breast and colon cancer (Aktan-Collan
et al., 2001; Lindberg & Wellisch, 2001). In NF1, MPNST is the most
commonly found malignancy with a lifetime risk of 8–13% in NF1
(Evans et al., 2002). In the current study groups, problems with self-
acceptance, low self-esteem, and limited socioeconomic participation
also seemed associated with the NF1-related cosmetic burden
(Vranceanu et al., 2013) and mental health problems.
Although primary concerns with cognitive deficits were not
reported, limited independence and poor social skills were worries of
both patients and parents, and symptoms of ADHD and ASD were
broadly described. Although more elaborately documented in children
with NF1, neurocognitive deficits also result in significant limitations in
adults with NF1 (Lehtonen et al., 2013). These findings underline the
presence and burden of cognitive deficits and their influence on mental
health, activities and participation. Such difficulties can be addressed
by an expert psychologist and/or intellectual disability physician (ID
physician).
7.3 | Activities and participation
Patients expressed frustrations about their inability to function
independently, limiting their socioeconomic participation. Difficulties
adjusting their life to the complications of NF1 and asking for help,
problems with organizing and planning daily life, and problems with
relationships and work were widespread. Poor social skills, reported in
children (Barton & North, 2004) and adults with NF1 (Pride et al.,
2013), affect the lives of adult patients, manifesting as problems initiat-
ing and maintaining social and romantic relationships. Also, negative
reactions from others to visible differences in appearance may affect
self-esteem and the forming of these social and romantic relationships
(Barke et al., 2014). Participants experienced problems with finding and
maintaining work, and problems with employers. During the interviews,
inadequate socioeconomic participation and loneliness appeared to be
associated with psychological complaints—which has been reported
before in teenagers and young adults with NF1 (Ejerskov et al., 2015;
Hummelvoll & Antonsen, 2013).
Family planning was an important theme, especially for young
adults, which is in line with previous research (Crawford et al., 2015).
Patients stated that they would want to have children without NF1
and that additional and timely education about genetics and reproduc-
tion was needed, although patients could not agree on the age at which
this information should be given. This indicates that HCPs should make
patient-specific decisions on the appropriate timing and level of detail
of this information.
7.4 | Environmental factors
Generally, adult patients and parents seemed to be well informed about
NF1, but they often noticed a lack of knowledge in people in their
direct environment. Both patients and parents experienced limitations
in their environment, such as lack of appropriate health care, lack of
multidisciplinary care, lack of family care, and inadequate support from
family, social networks, and employers.
7.5 | Parental stress
Parents of patients have previously participated in research to elucidate
the impact of NF1 on their children (Barke et al., 2016), yet the impact
on parents themselves has not been described yet. In our study,
parents of young adults reported many worries, high stress levels, and
little attention from HCPs for their complex parental role. Since the GP
is often well informed about family issues, she/he may have a crucial
role in referring to the appropriate type of support and mental health
care in the community.
Parental stress has been described in other pediatric cohorts with
neurodevelopmental syndromes or autism (Briegel et al., 2008; Hartley
et al., 2012; Pozo & Sarria, 2015). In children with NF1, mothers
reported higher parenting stress than the mothers of typically develop-
ing children (Esposito et al., 2014). The uncertainty of tumor progres-
sion may increase anxiety in both patients and parents of patients with
NF1. In future research, the contributing factors to parental stress
should be explored more fully, to identify parents at risk and to provide
targets for prevention and treatment. In addition to parental stress,
future research should also address the stress of other family members
with NF1.
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7.6 | Implications for transitional care
The transitional period from pediatric to adult care is known to be a
challenging phase for patients with NF1 and their parents (Oates et al.,
2013; Van Lierde et al., 2013), which was confirmed by our partici-
pants. For many patients, this transition did not proceed well. Although
expert adult care for the tumor phenotype was often accessible, finding
NF1 experts in other domains was difficult. The neuropsychological
deficits that frequently occur in patients with NF1 may decrease their
self-care and organizational capabilities, which puts them at risk for
problems during the transition to adult care (Van Lierde et al., 2013). At
this age, as is also the case in our sample, differences between parent-
and patient-reported worries underline that both parents and young
adults should be involved in the transitional process.
Previous studies on the transitional stage in patients with special
needs, such as intellectual disabilities or chronic disorders, have shown
that many adolescents experience significant problems with the continu-
ity of care during the transition to adult health care (Bindels-de Heus
et al., 2013; Fegran et al., 2014; Reiss et al., 2005). Often, after years of
periodic checkups by the pediatrician before adolescence, patients dis-
continued clinical evaluations or did not have contact with any health-
care professionals (Lotstein et al., 2009; Oates et al., 2013). In our study,
adult patients expressed a need for well-informed, accessible, and multi-
disciplinary NF1 expertise in close communication with the patient’s local
network and care providers. Continuous “chronic” care before, during,
and after transition (NICE, 2016) could be facilitated if these specialists
could also be “generalists” in adult care for people with neurogenetic dis-
orders in the way pediatricians are in pediatric care (Schor, 2015).
7.7 | Implications for adult care
From the worries mentioned above, conclusions can be drawn regard-
ing the organization and the content of care provisions. These findings
expand on current recommendations for the management of NF1
(Ferner et al., 2007). Suggestions for clinical practice are listed in
Table 4: “Addressing health care needs during NF1 consultation.”
In all groups, in addition to a local network of health-care professio-
nals including a GP, a desire for multidisciplinary expertise on adults with
NF1 was expressed, to obtain treatment and information on all domains.
As our results suggest, this expertise team should communicate closely
with local HCPs and would be responsible for diagnosis, timely follow-up,
second opinions, education, and assistance for the patients, parents, and
even the socioeconomic network. Screening and follow-up for mental
health problems should be included in routine follow-up, as this patient
group is at risk for psychiatric morbidity (Cohen et al., 2014; Deschee-
maeker et al., 2013; Mautner et al., 2015; Pasini et al., 2012; Pride et al.,
2013). In practice, this implicates that individuals with NF1 should be
offered structured care, including an accessible leading NF1-expert team
who routinely screens for physical and mental health and for limitations
in participation in social, occupational, or other meaningful daily activities.
Prevention and early intervention of mental health problems can be effi-
cient and cost-effective (WHO, 2016) and will ultimately improve socioe-
conomic participation and quality of life.
Since this study offered us a clear view of worries and care needs
within patients with NF1 and parents of patients with NF1, compari-
sons across different genetic neurodevelopmental syndromes might
help to find common factors and to contrast these findings to neuro-
cognitive, neurobehavioral, and environmental factors.
The organization of multidisciplinary and multilevel care requires a
method for severity assessment that includes the full impact of NF1 on
all ICF domains, including limitations in activities and participation.
Although the Riccardi scale for disease severity (Riccardi, 1992) has fre-
quently been used to assess impairments (Upadhyaya & David, 2012;
van der Vaart et al., 2013; Wolkenstein et al., 2001), many worries and
health-care needs of our respondents are not addressed by this scale,
since it mainly focuses on disease characteristics at a somatic level. This
suggests there is a need for assessing the full impact of NF1 on all ICF
domains, including limitations in activities and participation. In Tuberous
Sclerosis Complex, another neurocognitive and tumor predisposition
disorder, an attempt has been made to capture the burden of the dis-
ease by introducing the TAND checklist, encompassing “Tuberous
sclerosis-associated neuropsychiatric disorders.” This could serve as an
inspiration for such initiatives in the field of NF1 (de Vries et al., 2015).
7.8 | Strengths and limitations
In a qualitative observational study, the subjects that are to be dis-
cussed can be standardized, but conversations themselves cannot be
standardized. Given the sample size and the nature of this study, these
differences cannot be explored in a quantitative way. Future studies
with larger sample sizes and a quantitative may focus on systematic
differences between age groups, genders, or between parents and
patients.
Using focus groups as a means to explore worries and needs has
the possible drawback of participants feeling limited in their ability to
express feelings or concerns in the presence of other patients or
parent. In our focus groups, the atmosphere was quite open and
stimulating, and almost all participants actively joined the conversation.
However, problems with more intimate matters such as sexuality,
addiction, suicidal thoughts, and finance were hardly reported.
All patients who participated in this study were members of the
Dutch NF1 patient organization (NFVN). For this reason, our sample
may be biased toward relatively well-informed patients with a higher
level of education, and parents and patients may also have a more
severe phenotype. The Netherlands is a high-income country in West-
ern Europe. This should be taken into consideration when extrapolating
our results and recommendations to other societies where limitations
in care infrastructure, expertise, and finances may be more prevalent.
Since a large part of the participants were adults over 30 years old,
their reporting about the transitional period could have suffered from
“recall bias.” For some of them, this period was quite some time ago.
Health-care services probably may have changed in the past years.
However, we do feel that the recommendations in this article directly
result from the information of both younger and older participants.
The apparent data saturation during analysis suggests sufficient
sample size and data quality. Other strengths of the study were the
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large age range, the range in level of education, and reports from both
patients and parents. The ICF turned out to be an appropriate method
to describe patient-related problems in almost all areas of life. The uni-
versal nature of the ICF and the apparent shortcomings of Dutch
health care make our findings applicable to other countries where
multidisciplinary care is not routinely offered.
8 | CONCLUSION
This qualitative study offers a unique perspective on the worries and
health-care needs of adult patients with NF1 and their parents. The
care needs of NF1-patients and parents (during and after transitional
age) are diverse and need a multidisciplinary approach with systematic
evaluation of tumor growth, neuropsychiatric symptoms, and
socioeconomic limitations. Care infrastructure for adults should include
local health-care providers with experience in NF1 supported by an
accessible multidisciplinary NF1-expertise center. These different levels
of care could also address the need for information about the associa-
tion of NF1 with physical and mental problems, which could greatly
decrease the uncertainty both patients and parents need to live with.
Addressing physical health, mental health, and socioeconomic participa-
tion during regular consultations may improve health care and conse-
quently the quality of life of people with neurodevelopmental disorders.
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Patient information and education.
Referral to patient association, websites, and
brochures.
Other physical symptoms Fatigue, sleeping problems, headache, medication
side effects.
Somatic comorbidity.
Exclude tumor growth; identify appropriate care in
collaboration with GP.
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Inform GP, refer to clinical geneticist, gynecologist,
psychologist.
Need for information, education, and
support for patients, parents, siblings,
partners, GP’s, employers, and
network
Knowledge of symptoms, care infrastructure,
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1158 | RIETMAN ET AL.
Nederland) for their participation and support in this study. We are
grateful to Alanna Jacobs, who helped to edit the final version of
the manuscript.
CONFLICT OF INTEREST
None.
ORCID
Andre B. Rietman http://orcid.org/0000-0002-9004-0836
REFERENCES
Afridi, S. K., Leschziner, G. D., & Ferner, R. E. (2015). Prevalence and
clinical presentation of headache in a National Neurofibromatosis 1
Service and impact on quality of life. American Journal of Medical
Genetics Part A, 167(10), 2282–2285.
Aktan-Collan, K., Haukkala, A., Mecklin, J. P., Uutela, A., & Kaariainen, H.
(2001). Psychological consequences of predictive genetic testing for
hereditary non-polyposis colorectal cancer (HNPCC): a prospective
follow-up study. International Journal of Cancer, 93(4), 608–611.
ATLAS.ti. (2011). ATLAS.ti 6. GmbH SSD: Berlin.
Barke, J., Coad, J., & Harcourt, D. (2016). Parents’ experiences of caring
for a young person with neurofibromatosis type 1 (NF1): A qualita-
tive study. Journal of Community Genetics, 7(1), 33–39.
Barke, J., Harcourt, D., & Coad, J. (2014). It’s like a bag of pick and mix–you
don’t know what you are going to get’: Young people’s experience of
neurofibromatosis type 1. Journal of Advanced Nursing, 70(7), 1594–1603.
Barton, B., & North, K. (2004). Social skills of children with neurofibro-
matosis type 1. Developmental Medicine and Child Neurology, 46(8),
553–563.
Bindels-de Heus, K. G., van Staa, A., van Vliet, I., Ewals, F. V., & Hilber-
ink, S. R. (2013). Transferring young people with profound intellectual
and multiple disabilities from pediatric to adult medical care: Parents’
experiences and recommendations. Intellectual and Developmental
Disabilities, 51(3), 176–189.
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology.
Qualitative Research in Psychology, 3(2), 77–101.
Briegel, W., Schneider, M., & Schwab, K. O. (2008). 22q11.2 deletion
syndrome: Behaviour problems of children and adolescents and
parental stress. Child: Care, Health and Development, 34(6), 795–800.
Cohen, J. S., Levy, H. P., Sloan, J., Dariotis, J., & Biesecker, B. B. (2014).
Depression among adults with neurofibromatosis type 1: prevalence
and impact on quality of life. Clinical Genetics, 88(5), 425–430.
Constantino, J. N., Zhang, Y., Holzhauer, K., Sant, S., Long, K., Vallorani,
A., . . . Gutmann, D. H. (2015). Distribution and within-family specific-
ity of quantitative autistic traits in patients with neurofibromatosis
type I. Journal of Pediatrics, 167(3), 621–626.
Crawford, H. A., Barton, B., Wilson, M. J., Berman, Y., McKelvey-Martin,
V. J., Morrison, P. J., & North, K. N. (2015). The impact of neurofibro-
matosis type 1 on the health and wellbeing of Australian adults.
Journal of Genetic Counseling, 24(6), 931–944.
de Vries, P. J., Whittemore, V. H., Leclezio, L., Byars, A. W., Dunn, D.,
Ess, K. C., . . . Jansen, A. (2015). Tuberous sclerosis associated neuro-
psychiatric disorders (TAND) and the TAND checklist. Pediatric
Neurology, 52(1), 25–35.
Descheemaeker, M. J., Plasschaert, E., Frijns, J. P., & Legius, E. (2013).
Neuropsychological profile in adults with neurofibromatosis type 1
compared to a control group. Journal of Intellectual Disability Research,
57(9), 874–886.
Draucker, C. B., Nutakki, K., Varni, J. W., & Swigonski, N. L. (2017). The
health-related quality of life of children, adolescents, and young
adults with neurofibromatosis type 1 and their families: Analysis of
narratives. Journal for Specialists in Pediatric Nursing, 22(2), e12174.
Ejerskov, C., Lasgaard, M., & Ostergaard, J. R. (2015). Teenagers and
young adults with neurofibromatosis type 1 are more likely to experi-
ence loneliness than siblings without the illness. Acta Paediatrica,
104(6), 604–609.
Esposito, M., Marotta, R., Roccella, M., Gallai, B., Parisi, L., Lavano, S. M.,
& Carotenuto, M. (2014). Pediatric neurofibromatosis 1 and parental
stress: A multicenter study. Neuropsychiatric Disease and Treatment,
10, 141–146.
European-Commission. (2007). Inclusion strategy of the “youth in action”
programme (2007–2013). Retrieved from https://www.salto-youth.
net/downloads/4-17-1294/InclusionStrategyYiA.pdf
Evans, D. G., Baser, M. E., McGaughran, J., Sharif, S., Howard, E., &
Moran, A. (2002). Malignant peripheral nerve sheath tumours in neu-
rofibromatosis 1. Journal of Medical Genetics, 39(5), 311–314.
Evans, D. G., Howard, E., Giblin, C., Clancy, T., Spencer, H., Huson, S. M.,
& Lalloo, F. (2010). Birth incidence and prevalence of tumor-prone
syndromes: Estimates from a UK family genetic register service.
American Journal of Medical Genetics Part A, 152A(2), 327–332.
Farre, A., Wood, V., McDonagh, J. E., Parr, J. R., Reape, D., Rapley, T., &
Transition, C. G. (2016). Health professionals’ and managers’ defini-
tions of developmentally appropriate healthcare for young people:
Conceptual dimensions and embedded controversies. Archives of
Disease in Childhood, 101(7), 628–633.
Fegran, L., Hall, E. O., Uhrenfeldt, L., Aagaard, H., & Ludvigsen, M. S.
(2014). Adolescents’ and young adults’ transition experiences when
transferring from paediatric to adult care: A qualitative metasynthe-
sis. International Journal of Nursing Sciences, 51(1), 123–135.
Ferner, R. E., & Gutmann, D. H. (2013). Neurofibromatosis type 1 (NF1):
Diagnosis and management. Handbook of Clinical Neurology, 115,
939–955.
Ferner, R. E., Huson, S. M., Thomas, N., Moss, C., Willshaw, H., Evans,
D. G., . . . Kirby, A. (2007). Guidelines for the diagnosis and manage-
ment of individuals with neurofibromatosis 1. Journal of Medical
Genetics, 44(2), 81–88.
Friedman, J. M. (1999). Epidemiology of neurofibromatosis type 1.
American Journal of Medical Genetics, 89(1), 1–6.
Gilboa, Y., Rosenblum, S., Fattal-Valevski, A., & Josman, N. (2010). Appli-
cation of the international classification of functioning, disability and
health in children with neurofibromatosis type 1: A review. Develop-
mental Medicine and Child Neurology, 52(7), 612–619.
Hartley, S. L., Seltzer, M. M., Head, L., & Abbeduto, L. (2012). Psychologi-
cal well-being in fathers of adolescents and young adults with down
syndrome, fragile X syndrome, and autism. Family Relations, 61(2),
327–342.
Hummelvoll, G., & Antonsen, K. M. (2013). Young adults’ experience of
living with neurofibromatosis type 1. Journal of Genetic Counseling,
22(2), 188–199.
Hyman, S. L., Arthur Shores, E., & North, K. N. (2006). Learning disabil-
ities in children with neurofibromatosis type 1: Subtypes, cognitive
profile, and attention-deficit-hyperactivity disorder. Developmental
Medicine and Child Neurology, 48(12), 973–977.
Hyman, S. L., Shores, A., & North, K. N. (2005). The nature and fre-
quency of cognitive deficits in children with neurofibromatosis type
1. Neurology, 65(7), 1037–1044.
RIETMAN ET AL. | 1159
Johnson, H., Wiggs, L., Stores, G., & Huson, S. M. (2005). Psychological
disturbance and sleep disorders in children with neurofibromatosis
type 1. Developmental Medicine and Child Neurology, 47(4), 237–242.
Korf, B. R. (2015). Neurofibromatosis type 1 (NF1): Management and
prognosis. Retrieved from https://www.uptodate.com/contents/neu-
rofibromatosis-type-1-nf1-management-and-prognosis
Lai, J. S., Jensen, S. E., Patel, Z. S., Listernick, R., & Charrow, J. (2017).
Using a qualitative approach to conceptualize concerns of patients
with neurofibromatosis type 1 associated plexiform neurofibromas
(pNF) across the lifespan. American Journal of Medical Genetics Part A,
173(1), 79–87.
Lehtonen, A., Howie, E., Trump, D., & Huson, S. M. (2013). Behaviour in
children with neurofibromatosis type 1: Cognition, executive func-
tion, attention, emotion, and social competence. Developmental
Medicine and Child Neurology, 55(2), 111–125.
Leschziner, G. D., Golding, J. F., & Ferner, R. E. (2013). Sleep disturbance
as part of the neurofibromatosis type 1 phenotype in adults.
American Journal of Medical Genetics Part A, 161A(6), 1319–1322.
Lindberg, N. M., & Wellisch, D. (2001). Anxiety and compliance among
women at high risk for breast cancer. Annals of Behavioral Medicine,
23(4), 298–303.
Lotstein, D. S., Ghandour, R., Cash, A., McGuire, E., Strickland, B., &
Newacheck, P. (2009). Planning for health care transitions: Results
from the 2005–2006 national survey of children with special health
care needs. Pediatrics, 123(1), e145–e152.
Mautner, V. F., Granstrom, S., & Leark, R. A. (2015). Impact of ADHD in
adults with neurofibromatosis type 1: Associated psychological and
social problems. Journal of Attention Disorders, 19(1), 35–43.
Morris, S. M., Acosta, M. T., Garg, S., Green, J., Huson, S., Legius, E., . . .
Constantino, J. N. (2016). Disease burden and symptom structure of
autism in neurofibromatosis type 1: A study of the International NF1-
ASD Consortium Team (INFACT). JAMA Psychiatry, 73(12), 1276–1284.
NICE. (2016). Transition from children’s to adults’ services. National Insti-
tute for Health and Care Excellence. Retrieved from https://www.
nice.org.uk/guidance/ng43
NIH. (1987). Neurofibromatosis. NIH Consens Statement 1987 Jul 13–15,
6(12), 1–19.
Oates, E. C., Payne, J. M., Foster, S. L., Clarke, N. F., & North, K. N.
(2013). Young Australian adults with NF1 have poor access to health
care, high complication rates, and limited disease knowledge.
American Journal of Medical Genetics Part A, 161A(4), 659–666.
Pasini, A., Lo-Castro, A., Di Carlo, L., Pitzianti, M., Siracusano, M., Rosa,
C., & Galasso, C. (2012). Detecting anxiety symptoms in children and
youths with neurofibromatosis type I. American Journal of Medical
Genetics Part B, Neuropsychiatric Genetics, 159B(7), 869–873.
Pozo, P., & Sarria, E. (2015). Still stressed but feeling better: Well-being
in autism spectrum disorder families as children become adults.
Autism, 19(7), 805–813.
Pride, N. A., Crawford, H., Payne, J. M., & North, K. N. (2013). Social
functioning in adults with neurofibromatosis type 1. Research in
Developmental Disabilities, 34(10), 3393–3399.
Rauen, K. A., Huson, S. M., Burkitt-Wright, E., Evans, D. G., Farschtschi,
S., Ferner, R. E., . . . Upadhyaya, M. (2015). Recent developments in
neurofibromatoses and RASopathies: Management, diagnosis and
current and future therapeutic avenues. American Journal of Medical
Genetics Part A, 167A(1), 1–10.
Reiss, J. G., Gibson, R. W., & Walker, L. R. (2005). Health care transition:
Youth, family, and provider perspectives. Pediatrics, 115(1), 112–120.
Riccardi, V. M. (1992). Neurofibromatosis: Phenotype, natural history, and
pathogenesis (2nd ed.). Baltimore, MD: Johns Hopkins University Press.
Schor, E. L. (2015). Transition: Changing old habits. Pediatrics, 135(6),
958–960.
Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for
reporting qualitative research (COREQ): A 32-item checklist for inter-
views and focus groups. International Journal for Quality in Health
Care, 19(6), 349–357.
UNESCO Institute for Statistics. (2012). International standard classifica-
tion of education ISCED 2011. Montreal, Quebec: Author.
Upadhyaya, M., & David, C. (2012). Neurofibromatosis type 1. Berlin:
Springer-Verlag.
van der Vaart, T., Plasschaert, E., Rietman, A. B., Renard, M., Oosten-
brink, R., Vogels, A., . . . Moll, H. A. (2013). Simvastatin for cognitive
deficits and behavioural problems in patients with neurofibromatosis
type 1 (NF1-SIMCODA): A randomised, placebo-controlled trial. Lan-
cet. Neurology, 12(11), 1076–1083.
van Eeghen, A. M., Pulsifer, M. B., Merker, V. L., Neumeyer, A. M., van
Eeghen, E. E., Thibert, R. L., . . . Thiele, E. A. (2013). Understanding
relationships between autism, intelligence, and epilepsy: A cross-dis-
order approach. Developmental Medicine and Child Neurology, 55(2),
146–53.
Van Lierde, A., Menni, F., Bedeschi, M. F., Natacci, F., Guez, S., Vizziello,
P., . . . Esposito, S. (2013). Healthcare transition in patients with rare
genetic disorders with and without developmental disability: Neurofi-
bromatosis 1 and Williams-Beuren syndrome. American Journal of
Medical Genetics Part A, 161A(7), 1666–1674.
van Staa, A., van der Stege, H. A., Jedeloo, S., Moll, H. A., & Hilberink,
S. R. (2011). Readiness to transfer to adult care of adolescents with
chronic conditions: Exploration of associated factors. Journal of
Adolescent Health, 48(3), 295–302.
Vranceanu, A. M., Merker, V. L., Park, E., & Plotkin, S. R. (2013). Quality
of life among adult patients with neurofibromatosis 1, neurofibroma-
tosis 2 and schwannomatosis: A systematic review of the literature.
Journal of Neuro-Oncology, 114(3), 257–262.
Vranceanu, A. M., Merker, V. L., Park, E. R., & Plotkin, S. R. (2015). Qual-
ity of life among children and adolescents with neurofibromatosis 1:
A systematic review of the literature. Journal of Neuro-Oncology,
122(2), 219–228.
Wolkenstein, P., Zeller, J., Revuz, J., Ecosse, E., & Leplege, A. (2001).
Quality-of-life impairment in neurofibromatosis type 1: A cross-sectional
study of 128 cases. Archives of Dermatology, 137(11), 1421–1425.
Wolters, P. L., Burns, K. M., Martin, S., Baldwin, A., Dombi, E., Toledo-
Tamula, M. A., . . . Widemann, B. C. (2015). Pain interference in
youth with neurofibromatosis type 1 and plexiform neurofibromas
and relation to disease severity, social-emotional functioning, and
quality of life. American Journal of Medical Genetics Part A, 167A(9),
2103–2113.
World Health Organization (WHO). (2001). International classification of
functioning, disability and health (ICF). Retrieved from http://www.
who.int/classifications/icf/en/
World Health Organization (WHO). (2016). Mental health: Strengthening
our response. Retrieved from http://www.who.int/mediacentre/
factsheets/fs220/en/
How to cite this article: Rietman AB, van Helden H, Both PH,
et al. Worries and needs of adults and parents of adults with
neurofibromatosis type 1. Am J Med Genet Part A.
2018;176A:1150–1160. https://doi.org/10.1002/ajmg.a.38680
1160 | RIETMAN ET AL.
